Hrain Biotechnology
Shanghai
About Hrain Biotechnology
Hrain Biotechnology is a tumor immunotherapy technology developer, using the tumor immunotherapy technology CAR-T to provide cancer patients with precise treatment based on biological and cellular technology, and built centers in Beijing, Jiangsu, Chongqing, Henan and other places. Clinical trial platform.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Estimated revenue: $10K – $50K
- Total funding: $57.2M
- Funding stage: Late Stage Venture
- Last round: Series C (Apr 2021)
- Website: dashengbio.com
Industries & Categories
Biotechnology, Health Care
Social Profiles
Canonical: https://fsome.com/organization/hrain-biotechnology-85647 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.